Eisai Co.,Ltd.

4523

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-03FY2027 Q1

Revenue

8570.6100M JPY

YoY +6.7%

Operating Income

247.3100M JPY

YoY +19.2%

Net Income

423.3100M JPY

YoY -15.9%

EPS

64.7JPY

YoY +26.0%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

8253.8億円

6190.3億円

4126.9億円

2063.4億円

Rev: 7562.3億円Op: 537.5億円NI: 479.5億円

Rev: 7444億円Op: 400.4億円NI: 554.3億円

Rev: 7417.5億円Op: 534.1億円NI: 424.1億円

Rev: 7894億円Op: 543.8億円NI: 464.3億円

Rev: 8253.8億円Op: 441.4億円NI: 385.6億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income34.9%

Revenue Progress2343.300M

Revenue Forecast883500M

Net Income Progress182.400M

Net Income Forecast52300M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan